These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1374627)

  • 21. Mobilization of peripheral blood progenitor cells following CHOP treatment combined with delayed granulocyte colony-stimulating factor administration in patients with non-Hodgkin's lymphoma.
    Takano H; Sawada K; Sato N; Natoya A; Tarumi T; Hirayama S; Koizumi K; Takahashi TA; Sekiguchi S; Koike T
    Leuk Lymphoma; 1996 May; 21(5-6):473-8. PubMed ID: 9172813
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential high-dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma.
    Haas R; Moos M; Karcher A; Möhle R; Witt B; Goldschmidt H; Frühauf S; Flentje M; Wannenmacher M; Hunstein W
    J Clin Oncol; 1994 Aug; 12(8):1685-92. PubMed ID: 7518860
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hematopoietic recovery as a function of the number of autografted CD34+ cells: a retrospective study of 66 patients with malignant hematologic diseases].
    Boulassel MR; De Bruyère M; Nguyen BT; Straetmans N; Ferrant A
    Acta Clin Belg; 1999 Aug; 54(4):191-6. PubMed ID: 10544508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloablative therapy with blood stem cell transplantation is effective in mantle cell lymphoma.
    Haas R; Brittinger G; Meusers P; Murea S; Goldschmidt H; Wannenmacher M; Hunstein W
    Leukemia; 1996 Dec; 10(12):1975-9. PubMed ID: 8946940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors for rapid and sustained hematopoietic reconstitution by circulating progenitor-cell transplantation in non-Hodgkin's lymphoma.
    Barbui T; Cortelazzo S; Rossi A; Viero P; Bellavita P; Buelli M; Fracassetti D; Bassan R; Comotti B; Marchioli R; Marfisi RM; Rambaldi A
    Cancer Chemother Pharmacol; 1996; 38 Suppl():S110-4. PubMed ID: 8765429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effects of recombinant human interleukin 11 and granulocyte colony stimulating factor in mobilization for autologous peripheral blood stem cell transplantation].
    Zhu HY; DA WM; Gao CJ; Wang FF; Han XP; Li HH; Huang WR; Zhang YZ; Wang SH; Bo J; Jing Y; Jin HJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Apr; 16(2):345-9. PubMed ID: 18426662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant human granulocyte colony-stimulating factor (filgrastim) following high-dose chemotherapy and peripheral blood progenitor cell rescue in high-grade non-Hodgkin's lymphoma: clinical benefits at no extra cost.
    Lee SM; Radford JA; Dobson L; Huq T; Ryder WD; Pettengell R; Morgenstern GR; Scarffe JH; Crowther D
    Br J Cancer; 1998 Apr; 77(8):1294-9. PubMed ID: 9579836
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Factors which predict unsuccessful mobilisation of peripheral blood progenitor cells following G-CSF alone in patients with non-Hodgkin's lymphoma.
    Micallef IN; Apostolidis J; Rohatiner AZ; Wiggins C; Crawley CR; Foran JM; Leonhardt M; Bradburn M; Okukenu E; Salam A; Matthews J; Cavenagh JD; Gupta RK; Lister TA
    Hematol J; 2000; 1(6):367-73. PubMed ID: 11920216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of high-dose chemotherapy plus granulocyte colony-stimulating factor for the salvage of refractory or resistant-relapse lymphoma patients without stem cell support.
    Koç H; Arslan O; Gürman G; Akan H; Ozcan M; Ilhan O; Aydoğdu I; Arat M; Beksaç M; Konuk N; Uysal A
    Acta Haematol; 1997; 98(3):136-9. PubMed ID: 9352743
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of progenitor cell dose and preleukapheresis use of human recombinant granulocyte colony-stimulating factor on the recovery of hematopoiesis after blood stem cell autografting in children.
    Kawano Y; Takaue Y; Watanabe T; Saito S; Abe T; Hirao A; Sato J; Ninomiya T; Suzue T; Koyama T
    Exp Hematol; 1993 Jan; 21(1):103-8. PubMed ID: 7678082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor.
    Bensinger W; Singer J; Appelbaum F; Lilleby K; Longin K; Rowley S; Clarke E; Clift R; Hansen J; Shields T
    Blood; 1993 Jun; 81(11):3158-63. PubMed ID: 7684625
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Short-term rhG-CSF priming before chemotherapy does mobilize blood progenitors but does not prevent chemotherapy induced myelotoxicity: a randomized study of patients with non-Hodgkin's lymphomas.
    Hansen PB; Johnsen HE; Ralfkiaer E; Jensen L; Gaarsdal E; Hansen NE
    Leuk Lymphoma; 1995 Nov; 19(5-6):453-60. PubMed ID: 8590846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Collection of peripheral blood stem cells mobilized by high-dose Ara-C plus VP-16 or aclarubicin followed by recombinant human granulocyte-colony stimulating factor.
    Shimazaki C; Oku N; Ashihara E; Okawa K; Goto H; Inaba T; Ito K; Fujita N; Tsuji H; Murakami S
    Bone Marrow Transplant; 1992 Oct; 10(4):341-6. PubMed ID: 1384902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Aurlien E; Holte H; Pharo A; Kvaløy S; Jakobsen E; Smeland EB; Kvalheim G
    Bone Marrow Transplant; 1998 May; 21(9):873-8. PubMed ID: 9613778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Peripheral blood stem cell mobilization by chemotherapy with and without recombinant human granulocyte colony-stimulating factor.
    Schwartzberg LS; Birch R; Hazelton B; Tauer KW; Lee P; Altemose R; George C; Blanco R; Wittlin F; Cohen J
    J Hematother; 1992; 1(4):317-27. PubMed ID: 1285381
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A mononuclear cell dose of 3 x 10(8)/kg predicts early multilineage recovery in patients with malignant lymphoma treated with carmustine, etoposide, Ara-C and melphalan (BEAM) and peripheral blood progenitor cell transplantation.
    Smith RJ; Sweetenham JW
    Exp Hematol; 1995 Dec; 23(14):1581-8. PubMed ID: 8542950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical significance of recombinant human granulocyte colony-stimulating factor (rG-CSF) in the chemotherapy of patients with malignant lymphoma].
    Kuzuyama Y; Sonoda Y; Okuda T; Takashima T; Misawa S; Kashima K; Nakagawa H; Fujii H; Abe T
    Rinsho Ketsueki; 1992 Dec; 33(12):1789-96. PubMed ID: 1282572
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Recombinant human granulocyte colony-stimulating factor hastens granulocyte recovery after high-dose chemotherapy and autologous bone marrow transplantation in Hodgkin's disease.
    Taylor KM; Jagannath S; Spitzer G; Spinolo JA; Tucker SL; Fogel B; Cabanillas FF; Hagemeister FB; Souza LM
    J Clin Oncol; 1989 Dec; 7(12):1791-9. PubMed ID: 2479719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Engraftment of patients with lymphoid malignancies transplanted with autologous bone marrow, peripheral blood stem cells or both.
    Langenmayer I; Weaver C; Buckner CD; Lilleby K; Appelbaum FR; Longin K; Rowley S; Storb R; Singer J; Bensinger WI
    Bone Marrow Transplant; 1995 Feb; 15(2):241-6. PubMed ID: 7773213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term haematological reconstitution following BEAM and autologous transplantation of circulating progenitor cells in non-Hodgkin's lymphoma.
    Rossi A; Cortelazzo S; Bellavita P; Viero P; Bassan R; Comotti B; Marchioli R; Marfisi RM; Rambaldi A; Barbui T
    Br J Haematol; 1997 Mar; 96(3):620-6. PubMed ID: 9054673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.